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 “There is no scientific study more vital to man than the study of his own brain. Our entire 
view of the universe depends on it.”  
― Francis Crick
  
ABSTRACT  
 
Human  development  requires  the  generation  of  trillions  of  cells  with  myriad  functions  from  a  
single  cell.  This  requires  that  restriction  of  stem  cell  fate  competence  and  proliferation  are  
precisely  temporally  and  spatially  patterned  as  the  embryo  grows.  To  accomplish  this,  the  
chromatin  landscape  of  individual  stem  cells  progressively  constrains  gene  expression  in  a  
context  specific  manner  in  order  to  guide  cell  behavior.  In  turn,  this  context  is  provided  by  the  
cellular  environment  and  intrinsic  determinants  via  the  activity  of  transcription  factors.    
In  paper  I,  we  utilize  ChIP-­sequencing  to  study  the  overlapping  and  specific  activities  of  the  
transcription  factor  sex  determining  region  Y-­box  2  (SOX2)  in  the  developing  cortex,  spinal  
cord,  stomach  and  lungs.  We  show  that  cell  type  specific  binding  is  associated  with  tissue  
specific  gene  expression,  while  commonly  bound  cis-­regulatory  modules  neighbor  genes  
involved  in  the  core  processes  of  stem  cell  maintenance  and  proliferation.  
In  paper  II,  we  use  DNase-­  and  ChIP-­sequencing  to  demonstrate  that,  though  the  accessible  
chromatin  landscape  in  the  spinal  cord  and  cortex  are  highly  overlapping,  SOX2  binding  is  
primarily  specific  to  one  region.  We  find  that  this  is  due  to  an  association  with  the  specifically  
expressed  partner  transcription  factors  HOXA9  in  spinal  cord  and  LHX2  in  cortex,  which  are  
capable  of  respecifying  gene  expression  when  misexpressed.  
In  paper  III,  we  exploit  single  cell  RNA-­sequencing  to  establish  that  the  stem  cell  population  
of  the  early  cortex  expresses  high  levels  of  Sox2,  exhibits  features  of  multipotency,  and  is  
enriched  for  genes  involved  in  mitosis,  such  as  Ccnb1/2.  In  contrast,  the  committed  
progenitor  pool  expresses  high  levels  of  the  G1/S-­phase  genes,  including  Ccnd1,  which  is  
capable  of  inducing  differentiation  when  overexpressed.    
In  paper  IV,  we  find  that  Sox2  acts  in  a  dose-­dependent  fashion  to  control  proliferation  in  the  
developing  cortex  by  directly  repressing  Ccnd1.  We  show  that  this  is  accomplished  via  the  
binding  of  off-­consensus  sites  in  the  Ccnd1  promoter,  and  an  association  with  Wnt  signal  
transducing,  TCF/LEF,  transcription  factors  and  their  established  co-­repressor,  TLE1.  
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1   INTRODUCTION  
 
1.1   EMBRYOGENESIS  
The generation of an adult human from a single cell is amongst the most remarkable of 
phenomenon in our known universe. This feat requires that the blueprints for all of our 
attributes are contained within and decoded by the activities of twenty-three pairs of linear 
molecules of DNA, which meet for the first time in the fertilized egg. Following conception, 
a carefully orchestrated and amazingly reproducible series of chemical reactions unfold to 
give rise to trillions of individual cells (1), with myriad different functions, in an organism 
capable of understanding the process from which it arose. Although our actions are carried 
out by differentiated cells with specific roles, the construction and maintenance of our body 
relies on stem cells. 
During development, stem cells become progressively fate restricted from the totipotency of 
the fertilized egg to the multipotency or unipotency of tissue resident stem cells, which are 
responsible for maintaining individual adult organs (2). Recent years have brought incredible 
advances to our understanding of the extent to which our own organs turn over from stem 
cells during our life time, such that some of our largest organs are regrown multiple times 
every year (3-6). However, it is as embryogenesis proceeds that individual stem cells become 
fated to distinct lineages, and it is these decisions that my thesis will focus upon. 
After fertilization, individual cells at the four cell stage begin to show molecular signatures 
revealing their bias towards trophoectoderm, which will become the placenta and 
extraembryonic support cells in utero, or inner cell mass fates (7-8). The inner cell mass will 
progressively give rise to the hypoblast, which will form the yolk sac, and a single cell layer 
of epiblast cells, which will form every part of the embryo from a single layer of cells (9). 
Once it has expanded, an organizing center is established on the epiblast surface and 
orchestrates localized cell invagination in a process called gastrulation (from latin stomach – 
formation) (10). While the invaginated cells will form the endoderm and mesoderm, the 
surface of the epiblast will form the ectoderm (11). These three germ layers will each form 
well defined organs within the developing embryo, and comprise the first major restriction in 
embryonic stem cell (ESC) fate (12). Thus, in what was a uniform cell layer, gastrulation 
simultaneously restricts cell fate and imbues dorsal-ventral (back-belly), anterior-posterior 
(head-foot) and right-left axes based on the orientation of organizer migration. 
While the organizer is still migrating posteriorly, further inductive events continue to unfold 
anteriorly. At the midline of the mesodermal cell layer, a newly formed structure called the 
notochord signals to the overlying ectoderm to take on a neuroectodermal fate and form the 
neural plate, which will fold into the neural tube in a process called neurulation (13). This 
tube will form every cell of the central nervous system (CNS), while a migratory derivative 
of it called the neural crest, will form numerous cell types, including the peripheral nervous 
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system (PNS) (14). The non-neural ectodermal cell layer will give rise to the outer most 
barriers of the body, such as the epidermis, hair and nails (15). Similarly, the mesoderm will 
give rise to many defined internal structures, such as muscle, fat, bone and cartilage, as well 
as the urinary and immune systems (16). Finally, the endodermal cell layer will also form a 
tube, which is the precursor to our respiratory and digestive systems (17). Through these 
various lineage trajectories, all the cells of the human body are each narrowly fate restricted 
to their specific roles.  
The mechanisms that segregate lineages at various steps can fall into various categories. As 
an example, the mammalian cortex is anatomically described to consist of six neuronal layers, 
which all utilize the neurotransmitter molecule glutamate, but have different axonal targets, 
such that upper layer neurons project to other neurons in the cortex, while deep layer neurons 
project to other regions of the brain (18-19). However, in order to give rise to neurons with 
these different attributes at the correct place and time, cortical stem cells must be instructed in 
  3 
a process called patterning.  If we follow the example of the lineage leading to the generation 
of a cortical neuron from neural tube precursors, the first consideration we must take into 
account is the location where the neuron is born within this stem cell population. Termed 
spatial patterning, this means that there are specific signals present where cortical neurons 
will be born, from the dorsal half of the neural tube, at its anterior tip – the forebrain or 
telencephalon (20). In this case, the location of cortical stem cells imbues them with both the 
ability to generate the structure of the cortex, as opposed to that of the spinal cord for 
example, as well as the predisposition to give rise to neurons that utilize glutamate as a 
neurotransmitter, in comparison to those born ventral to the cortex, which use gama-
aminobutyric acid (GABA) as a signaling molecule (21). Following cortical fate restriction, 
the different layers of neurons are all born from the same stem cell pool in a sequential 
fashion, such that the deep layers arise first and are migrated past by later born upper layer 
neurons (22). Thus, once spatially patterned, cortical stem cells must then shift their 
competence as neurogenesis proceeds, in a process termed temporal patterning. By repeatedly 
utilizing these complimentary strategies to make progressively more specific lineage 
decisions, a single stem cell can give rise to an independent organism with a brain capable of 
understanding and studying these processes. 
 
1.2     THE  CHROMATIN  LANDSCAPE  
The human genome project has made clear that, although the blueprints for human 
development are contained within every cell of our body, decoding the information into 
messenger RNA (mRNA) and protein expression profiles occurs in a cell type and context 
specific manner (23). This is because the genome never exists as isolated molecules of DNA, 
but instead continuously interacts with transcription factors, histones and architectural 
proteins, which imbue cells with their specific transcriptional profiles (24). Since cis-
regulatory module (CRM)-promoter interactions are essential for gene expression, these 
factors regulate which regions of the genome are accessible to the transcriptional machinery 
(25) and limit the CRMs that can interact with a gene’s promoter (26). 
In general, as stem cells become more specified during development, and then differentiate 
into distinct cell types, the genome becomes progressively less accessible, though this feature 
has been shown to be paralleled by the selective formation of de novo open chromatin at 
specific CRMs (27). This suggests that certain transcription factors with pioneering function, 
the ability to bind and open heterochromatin, may play a unique role in controlling stem cell 
fate competence during development (28).  However, it is also important to note that the 
degree of chromatin accessibility can vary greatly between open and closed.  Histone 
octamer’s tails can be modified in many ways that affect their association with DNA, and can 
even form higher order heterochromatin structures involving linker histones and associated 
proteins (29-30). Thus, although essential to cell fate decisions, chromatin accessibility is 
highly dynamic, and the process of somatic cell reprogramming clearly demonstrates that 
chromatin accessibility can be reset. Moreover, the finding of reprogramming factors in 
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cancer cells illustrates the importance of maintaining tight regulation of chromatin 
accessibility (31). 
Despite its necessity, DNA accessibility is not sufficient to specify transcriptional programs. 
Due to the size of the genome, the number of potential CRM-promoter interactions must be 
limited in order to ensure accurate gene expression, and this is achieved by insulating 
different regions from interacting with one another. Upon fertilization, the genome is 
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unorganized, with very little compacted heterochromatin or nuclear architecture (32). As 
transcription begins, architectural proteins, such as CCCTC binding factor (CTCF) and the 
Cohesin and Mediator complexes, bind to essential regulatory domains termed topologically 
associated domain (TAD) boundaries. These organize both large, megabase sized TADs, 
which are less variable between cell types, and smaller, kilobase sized loops, which are 
highly dynamic and cell type specific (33). Essentially, CRM-promoter interactions can only 
occur within a TAD loop, and if a TAD boundary is lost it can result in ectopic regulatory 
interactions and deregulated gene expression. Importantly, several transcription factors shown 
to be key determinants of cell state have been shown to be enriched at TAD boundaries, and 
thus have direct input on the cell type specific architecture of the genome (34). 
Although complex, the biology of transcription functions just as any chemical reaction, 
whereby modifications and interactions occur in a concentration dependent manner. By 
targeting relevant CRMs, transcription factors bring the transcriptional machinery into 
proximity with specific genes and promote their expression (33). In certain cases, around key 
cell fate genes, termed super enhancers (SEs), many such CRM associations come together to 
form densely packed areas of protein aggregation. These are so dense, and involve so many 
interactions, that they exclude water from their cores and form almost pure protein droplets 
within the otherwise aqueous environment. This produces highly efficient transcription 
factories, which drive high expression levels of nearby genes (35). In addition, the large 
number of interdependent interactions involved make SEs highly sensitive to the 
concentrations of their constituent proteins (36). Notably, it is precisely this mode of 
sensitivity to transcription factor levels that is required for the dynamic regulation of cell fate 
decisions during embryogenesis. 
Thus, by limiting what genes and CRMs are accessible to the transcriptional machinery, stem 
cells become progressively fate restricted during development. However, it is by biasing the 
probability of transcription from specific genes that the chromatin landscape generates 
precise transcriptional profiles from the stochastic activities of molecules in the nucleus. 
 
1.3   TRANSCRIPTION  FACTOR  ACTIVITY  
Because the chromatin landscape is primarily shaped by proteins with little respect for which 
segment of the genome they are interacting with, the specificity required for distinct 
transcriptional states must be mediated by transcription factors, which bind to precise 
genomic regions based on their DNA sequences. The human genome encodes over a 
thousand transcription factors, which can be grouped based on their DNA binding domains, 
as these each bind to characteristic DNA sequence motifs (37). Despite the number of factors, 
their recognition sequences are relatively short, and thus the size of the human genome 
implies that the specificity provided by individual factors is still not sufficient to direct the 
processes necessary for development. To overcome this, transcription factors often bind in 
complexes, which not only increases their affinity for longer and more distinct DNA 
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sequences, but also provides specificity to the co-factors they will recruit for gene regulation 
in different contexts (38-39). 
As stem cells differentiate from a totipotent state, the competition and cooperation between 
transcription factors is essential to directing individual cells towards specific fates. Amongst 
the most studied transcriptional complexes in biology is that formed by the core ESC 
transcription factors SOX2 and POU5F1, which maintain the ESC transcriptional program 
despite the relaxed chromatin environment of ESCs (40). However, when SOX17 becomes 
expressed in presumptive endodermal cells, it competes with SOX2 to partner with POU5F1, 
and causes a shift in binding to a slightly compressed DNA motif (41). This difference is 
sufficient to disrupt the ESC state and begin activating the endodermal transcriptional 
program. This is only one of many examples where the switching of partner factors re-
specifies the binding of a core transcription factor. 
Many transcription factors can act to both enhance and repress transcription of different target 
genes within the same cell at the same time (42). In order to perform these opposing actions 
simultaneously, individual transcription factors act in a context specific manner. This context 
can be provided by the CRM sequences surrounding different target genes, via attraction of 
distinct partner transcription factors and co-factors, or by other components within the 
cellular or nuclear environment (42). Transcription factors acting downstream of signaling 
pathways almost always function in this manner, such that the active signaling pathway 
permits nuclear localization of a co-activator that displaces a co-repressor and thereby 
induces target gene expression (43). Additionally, dependent on the cellular environment, 
transcription factors can be covalently modified and thus alter their interacting co-factors 
(44). Finally, variations in the splicing patterns of transcription factor genes can generate 
proteins with highly divergent functions (45). 
Transcription factor activity is central to cell fate determination and must be tightly regulated 
in a context specific manner. In order to simultaneously regulate the global chromatin 
landscape and distinct activities of specific CRMs throughout development, transcription 
factors must utilize several strategies. First, master regulators of cell fate identity bind to 
TAD boundaries and SEs around key genes to assemble large protein complexes and regulate 
the architecture of the nucleus (34). Second, by utilizing different partner transcription 
factors, an individual factor can target divergent sets of CRMs and genes in diverse cell types 
(38). Lastly, the co-activators and co-repressors recruited by an individual factor can vary 
greatly dependent on the partner factors utilized around specific genes, and the modifying 
enzymes present to regulate their interactions (42). Thus, transcription factors provide the 
foundation required for cell type specific gene regulation via their context dependent 
activities. 
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1.4   SIGNALING  PATHWAYS  
The serial restriction of stem cell fate necessary for embryogenesis is executed within cell 
populations, which must give rise to appropriate cell types in a defined order and pattern. 
These processes require fine-tuned coordination between cells at a distance from one another. 
This has been shown to be mediated by only eleven signaling pathways, which act by binding 
to receptors on target cells and affecting intracellular events that influence transcriptional 
regulation (43). While the Notch and Hippo pathways act only on neighboring cells, by cell 
surface bound ligands, the fibroblast growth factor (FGF), epidermal growth factor (EGF), 
Wingless/Integration-1 (Wnt), Transforming Growth Factor Beta (TGFß), Hedgehog (Hh), 
cytokine tyrosine kinase, Jun kinase, nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF-kB) and retinoic acid receptor (RAR) pathways act at distance by secreting ligands 
into the extracellular space (43). Here, I will briefly summarize the soluble morphogen 
pathways relevant to my thesis, and how these act on target cells in a concentration dependent 
manner to pattern embryonic structures. 
To begin with the earliest patterning events, organizer induction has been shown to be 
executed by the simultaneous activation of the Wnt and TGFß pathways in presumptive 
organizer cells within the epiblast (46). Wnt genes code for proteins, which are secreted into 
the extracellular space from source cells following serial post-translational modifications 
(47). Upon diffusion to target cells, WNT proteins bind to Frizzled (FZD) and lipoprotein 
receptor-related (LRP) receptors at the cell surface, which allows them to recruit Disheveled 
(DSH) and AXIN proteins to the inner surface of the cell membrane (48). AXIN is a key 
component of the destruction complex, which also consists of glycogen synthase kinase 3 
(GSK3), adenomatosis polyposis coli (APC) and casein kinase 1a (CK1a). One of the key 
targets of the destruction complex is the cell-cell adhesion molecule ß-catenin, which it 
ubiquitinates and targets for degradation (49). When AXIN is recruited to the cell membrane 
by active Wnt signaling, soluble ß-catenin begins to accumulate in the cytoplasm and 
translocates to the nucleus (50). In canonical Wnt signaling, ß-catenin binds to members of 
the T-cell factor/lymphoid enhancer factor (TCF/LEF) family of transcription factors upon 
translocation to the nucleus (51), where it displaces transducin like enhancer of split (TLE1) 
co-repressors and acts as a potent co-activator of their target genes (52). 
The TGFß superfamily of ligands includes bone morphogenic proteins (BMPs), growth 
differentiation factors (GDFs), Activins and TGFßs, which are each involved in various 
cellular patterning events (53). Despite the diversity of the family, they all act by bringing 
together different type I and type II receptors (Alk genes), which induces the phosphorylation 
of the type I receptor (54). Activated type I receptors then phosphorylate either Smad1, 
Smad5 or Smad8 in the BMP signaling pathway, or Smad2 or Smad3 in TGFß, Activin and 
most GDF pathways (53). These phosphorylated Smads then have a great affinity for Smad4, 
which mediates their translocation to the nucleus and specific transcriptional activities (55). 
Once the telencephalon has been established, morphogen signaling is essential for the 
regionalization of the brain. First, the cortex must be distinguished from the ventral forebrain, 
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which will give rise to the ganglionic eminence (56). Subsequently, it must be patterned 
along its surface in order to generate all of the specific areas dealing with everything from 
sensory perception to speech (57). The molecules most characterized in these events are 
Sonic Hh (SHH), which broadly patterns the dorsal-ventral axis of the neural tube (58-59), 
and FGF8/17, which have been shown to be essential for cortical surface arealization (60). In 
Shh signaling, the cholesterol bound SHH ligand is excreted from signaling center cells (61), 
notably those of the notochord and floor plate, and binds to Patched (PTCH) receptors on 
target cells (62). This binding relieves PTCH receptor inhibition of the transmembrane 
protein Smoothened (SMO), which in turn leads to stabilization of GLI activator transcription 
factor function (62). This creates a gradient of GLI activator to GLI repressor activity, which 
is highest near ventral SHH sources and most repressive in the cortex, and thus acts as a 
potent regulator of telencephalon patterning (63). 
  9 
Upon establishment of a cortical fate within the telencephalon, FGF8/17 begin to be 
expressed from the anterior midline of the cortex (57). FGF8/17 bind to the extracellular 
regions of FGF receptors (FGFR) 1-4, and mediates their dimerization. This results in the 
trans-autophosphorylation of their intracellular kinase domains and activation for downstream 
signaling (64). As with other growth factor receptors, activated FGFRs can phosphorylate 
proteins involved in the major intracellular kinase pathways: mitogen activated protein kinase 
(MAPK), phosphatidylinositide-3-kinase (PI3K)-Akt, phosphoinositide phospholipase C 
(PLC) and signal transducer and activator of transcription (STAT) (65). Each of these have 
highly specific functions in diverse cellular processes and lead to various transcriptional 
outputs. However, in the context of cortical patterning, loss of FGF8 leads to a drastic 
reduction in anterior motor cortex areas at the expense of an expansion in the more posterior 
somatosensory and visual areas (66-67). 
Along with the other signaling pathways mentioned above, the Wnt, TGFß, Shh and FGF 
pathways play crucial roles at various stages of embryonic development. By consecutively 
restricting stem cell fate, and then reapplying the same pathways on the new landscape of cell 
competence, the embryo rapidly produces finely patterned cellular diversity from a small, 
uniform population of cells. 
 
1.5   PROLIFERATION  
The cell cycle is a core stem cell processes, and its components have also been demonstrated 
to play important roles in differentiation and cell fate determination (68-69). In order to 
generate the massive cell numbers required in the construction and maintenance of an adult 
human, stem cells divide rapidly during embryogenesis, and then slow their proliferation as 
we age (70). As DNA damage and mutations can only become fixed in the stem cell genome 
when those errors are replicated and inherited by daughter cells, it is important for the process 
of cell division to be continuously checked to allow for repair (71). Thus, in order to sustain 
their longevity, stem cells utilize several strategies and mechanisms to ensure the fidelity of 
their reproduction. 
One important strategy, widely applied to prevent replicative errors and sustain stem cell 
endurance, is to reduce their overall number of divisions. This is achieved by a stem cell 
dividing to produce one stem cell, and one transit amplifying cell. Transit amplifying cells are 
able to divide a defined number of times before all of their progeny differentiate into defined 
cell types dependent upon the tissue in which they were generated (72). Since an individual 
differentiated cell has a limited impact on an individual’s health and committed transit 
amplifying cells produce a limited number of them, they replicate their DNA more rapidly 
than stem cells, and thus take on the mutagenic replicative burden (73-74). This hierarchy of 
proliferation is utilized extensively throughout the developing embryo and in adult tissue 
maintenance, and is tightly integrated with the process of differentiation (75). 
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Despite variations in kinetics, the cell cycle proceeds as a repeated order of events, regardless 
of the cell type. As a newborn stem cell separates from its sister, it re-enters a new cell cycle 
that begins in gap 1 (G1) phase, and progresses through DNA synthesis (S), gap 2 (G2) and 
concludes with mitosis (M) (76). During G1, various inputs lead to the accumulation of D-
type cyclins (CCND1-3), which partner with cyclin dependent kinases (CDK) 4 and 6 upon 
reaching sufficient levels (77). Active CDK4/6-CyclinD complexes stimulate cell cycle 
progression by phosphorylating retinoblastoma protein (RB) and inhibiting its binding to E2 
factor (E2F) family transcription factors (78). Upon release, E2F factors bind to and activate 
their downstream target genes, which include the E-type (CCNE1/2) cyclins and A-type 
(CCNA1/2) cyclins (79). CyclinEs accumulate rapidly at the end of G1 and partner with 
CDK2 to further phosphorylate RB and other targets involved in the activation of DNA-
synthesis (80). CyclinAs accumulate slowly throughout DNA-synthesis and G2, but when 
partnered with CDK1/2 they mediate the phosphorylation of targets involved in DNA-
synthesis progression and entry into G2 (81). Upon completion of DNA-synthesis, B-type 
cyclins (CCNB1-3) accumulate and ultimately license the entry into and progression of M-
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phase (82-83). M-phase unfolds as pro-, meta-, ana- and telophases, and begins as 
centrosomes migrate to opposing sides of the cell and extend spindles between them, the 
nuclear envelope dissolves and individual chromosomes condense into discrete chromatids, 
with sisters joined by a centromere. Once the chromatids have aligned along the center of the 
cell and the mitotic spindles have attached to each centromere, this arrangement is resolved 
when the centromeres split and sister chromatids migrate to opposite poles of the cell. The 
whole process is completed in cytokinesis, when the cell membrane pinches in, divides the 
daughter cell’s cytoplasm and permits cells to reconstruct the nuclear envelope and re-enter 
G1 (84).  
Although the ordered series of events that unfold during cell division are licensed by 
Cdk/Cyclin complexes, the activity of these is heavily regulated in order to ensure the fidelity 
of stem cell division. For instance, at all stages of the cell cycle, DNA breaks can be detected 
by ataxia telangiectasia mutated (ATM)/ataxia telangiectasia and Rad3-related (ATR) 
kinases, which directly phosphorylate tumor protein 53 (TP53) (85). TP53 is widely regarded 
as one of the most essential tumor suppressors in cell biology, as it directly activates cyclin 
dependent kinase inhibitor p21 (CDKN1A), which results in cell cycle arrest, and bcl2-like 
protein 4 (BAX), which pushes cells towards apoptosis (86). During normal cell cycle 
progression, Cdkn1a and other cyclin dependent kinase inhibitors, CDKN1B (p27), 
CDKN1C (p57), CDKN2A (p16), CDKN2B (p15), CDKN2C (p18) and CDKN2D act to 
inhibit CDK2 and/or CDK4/6 containing complex activity (87). Finally, CDK1 activity is 
competitively repressed by WEE1 G2 checkpoint kinase phosphorylation and activated by 
cell division cycle 25 (CDC25) phosphatase activity (88). Thus, many layers of cell cycle 
licensing proteins and their inhibitors act during specific cell cycle phases in order to 
integrate cellular inputs and ensure orderly cell cycle progression.  
 
1.6   NEUROGENESIS  
Ultimately, a neural stem cell’s role is to generate the differentiated progeny that will play 
functional roles in the activity of the adult brain. How to balance the maintenance of a stem 
cell population with commitment to differentiation is a question, which has important 
implications for understanding how our brain is formed during development. In addition, 
these processes continue to be active as adults, with important implications to mental health, 
and tumor formation. Thus, I will summarize the key pathways regulating neurogenesis with 
a focus on the cortex. 
As mentioned above, the Notch pathway acts only between cells in contact with one another 
and executes the lateral inhibition of differentiation in cells neighboring those that have 
committed to neurogenesis. Upon commitment, progenitors upregulate Delta-like (DLL1-4) 
and Jagged (JAG1/2) ligands, which they present on their cell surface (89). These bind to 
NOTCH receptors on neighboring cells, and induce their cleavage, which results in the 
release of the NOTCH intracellular domain (NICD) in those cells (89). The NICD is then 
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transported to the nucleus, where it displaces co-repressors, such as nuclear co-repressor 2 
(NCOR2), from recombination binding protein suppressor of hairless (RBPJ) and activates its 
target genes in cooperation with Mastermind-like transcriptional coactivator (MAML1) (90). 
Key target genes activated by NICD/RBPJ include members of the Hairy/enhancer of split 
(HES1-7) family of basic helix-loop-helix transcription factors (bHLH), which directly 
repress expression of proneural bHLH transcription factors such as Neurogenins 
(NEUROG1-3) and Achaete-scute like (ACL1-5) (91). A threshold of NEUROG or ASCL 
protein activity is a powerful pathway committing cells to differentiation, as it triggers a 
cascade of other bHLH proteins (92-94). Sufficient concentrations are essential, as all 
proneural bHLH proteins must bind an E protein (TCF3, 4 or 12) partner in order to bind 
DNA. This means that proneurals must compete with E-protein homodimers and 
sequestration by the inhibitor of DNA-binding (ID1-4) protein family (95). 
In parallel to the environmental regulation of differentiation imposed via Notch signaling, 
intrinsic determinants also play powerful roles in influencing commitment decisions. The 
sex-determining region Y-box (SOX) family of transcription factors all share a high mobility 
group box DNA binding domain, and play important roles at all stages of neurogenesis. The 
SOXB1 (Sox1-3) group of proteins have been shown to strongly repress differentiation, even 
in the absence of active Notch signaling (96-97). SOX2 expression levels have been shown to 
be inversely correlated with the degree of commitment to neurogenesis (98), and it is one of 
the core factors used to reprogram somatic cells back to a pluripotent ESC state (99). In 
contrast, the SOXB2 group protein SOX21 is strongly upregulated by SOXB1s and has been 
demonstrated to force cell cycle exit without committing cells to neurogenesis, likely via a 
tumor suppressor pathway shared with SOX5 and SOX6 (100-101). Once stem cells have 
committed to neurogenesis, the SOXC group (Sox4,11 and 12) are upregulated by bHLH 
proteins, whereby they directly activate neuronal genes, such as Beta-III-tubulin (TUBB3) 
(102). These examples suggest that the application of single families of transcription factors 
to a linear differentiation pathway has particular potency in regulating the progression of 
neurogenesis at least partly due to the competition for, and differential regulation of, their 
shared target genes. 
In the cortex, neurogenesis begins around E10.5 as radial glia cell (RGC) nuclei migrate 
between the apical ventricular surface, where mitotic cell division occurs, and the 
subventricular zone (SVZ), where DNA-synthesis occurs. All RGCs retain both an apical foot 
and a basal process that extends to the surface of the cortex, as this allows them to receive 
soluble signals from the ventricular zone and provides a scaffold for newborn neurons to 
migrate along (103). Upon commitment to differentiation by NEUROG1-3, progenitors 
upregulate B-cell translocation gene 2 (BTG2) and lose their apical foot. The vast majority 
will then enter an EOMES expressing, transit amplifying state that occurs in the SVZ and 
outer SVZ and can last over ten cell divisions before terminal neurogenesis in humans (104). 
This system permits the generation of over a thousand neurons from a single RGC division, 
and is one mechanism that has allowed the massive expansion of our brains from ancient 
molecular mechanisms. 
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1.7   CONCLUDING  REMARKS  
For a single species, humans have put an unprecedented mark on the planet earth. Many of 
our most sacred documents suggest that this is our right, but our origins and actions arise 
from the same physical and chemical reactions as any process in the universe. Moreover, the 
similarities between early human embryos and those of other animals provides a humbling 
counter perspective to any belief in human exceptionalism (105). Ultimately, the path leading 
to humanity’s ascension on earth is the culmination of billions of years of reproductive 
chemistry, and a respect for that history is essential to guiding our future. 
Our modern disconnect from nature may make it difficult to believe, but the attributes that 
separate us from other species are not as grand as often purposed. This has been powerfully 
demonstrated by the incredible similarity between the sequence of our genome and those of 
other animals (106). For example, SOXB1 proteins have existed for over a billion years, since 
the innovation of multicellularity. However, genomic data has also given us the first solid 
leads to understanding what it is that has allowed us to be so successful. Unsurprisingly, this 
information has pointed strongly to the structure of our brains as the target of the majority of 
recent mutations in our genome (107). 
The cortex makes up over three quarters of the human brain’s volume, and has shown the 
most rapid relative expansion of any part of the brain when compared to rodents (108). 
Interestingly, regardless of cortical area, radial units that extend from the ventricle to the 
cortical surface form integrated circuits, which receive widespread inputs, project to other 
cortical areas from the upper layers and transmit signals to subcortical areas from the deeper 
layers (19). Thus, increasing the processing power of our brains during evolution has at least 
partly been achieved in a similar way to that which we have used to develop computers: 
simply adding more transistors.  
By adding slowly to an existing foundation, humanity has achieved feats that would be 
unimaginable to our ancestors. The central driver of this has been our ability to understand 
previous accomplishments, disseminate our advances and build upon their work. Although 
this cycle is mediated in human societies by our unique capability for writing and language, 
the process fundamentally resembles what life has achieved by utilizing the molecular 
properties of nucleic acids. Thus, it is important to remember that in the history of life on 
earth, there have been many false starts and dead ends. Similarly, there have been many 
human ideas that have gained large followings, but that have ultimately turned out to be 
unproductive. In order to avoid our own species becoming another truncated branch on the 
tree of life, it will be essential that we utilize the skills that got us to this point in order to find 
a sustainable way forward.  
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2   METHODS  
 
2.1   MASSIVELY  PARALLEL  SEQUENCING  
Modern sequencing techniques generate huge quantities of data by sequencing many short 
pieces of DNA in parallel. The Illumina platform begins with DNA fragments between 200 
and 1000 base pairs being run over a specialized flow cell and binding to the short DNA 
molecules embedded within. By serially binding both ends of the fragments to be sequenced, 
priming their duplication and releasing one end, bridge amplification can then multiply 
individual molecules within a defined area to produce a spot (109). 
A mix of primed individual nucleotides (dNTPs), where each nucleotide is labelled with a 
different fluorescent dye, is then spread over the flow cell. When free nucleotides are washed 
away, this leaves each spot fluorescing in a single color dependent upon what the next base in 
the sequence of the spotted fragments was. After a camera has taken a picture of each of the 
millions of spots, the fluorescent molecules are then quenched and the process is repeated to 
build up the sequence of each spot. When these sequences are aligned to a corresponding 
genome assembly, the resultant reads cluster together at the loci that gave rise to the 
sequencing sample, whether in gene bodies for RNA-sequencing or at CRMs for DNase-
sequencing or ChIP-sequencing (109). 
The novelty of this approach is not only in the amount of data generated and its cost 
efficiency, but in that by performing the sequencing reactions in parallel using the same 
primers, it has allowed the unselected sequencing of samples of unknown contents. To 
illustrate its effect on biological research, simply consider the near exponential growth in 
sequences deposited in public databases (110). 
 
2.2   GENOME  WIDE  TRANSCRIPTION  FACTOR  AND  CHROMATIN  PROFILING  
Our ability to understand the state of the chromatin landscape and transcription factor’s 
binding profiles in vivo has taken massive leaps in recent years due to advances in 
sequencing technology. By performing classical experiments used to analyze the accessibility 
of DNA and occupancy of transcription factors, and using them as input to high throughput 
sequencing, we can now analyze their results across the entire genome. 
Deoxyribonuclease I (DNase) is an enzyme that cleaves DNA sequences in a sequence 
unspecific manner. However, in order to do so, it requires unhindered access to both sides of 
the helix, and thus its activity is blocked when DNA is bound by transcription factors or 
histones. Thus, by applying DNase to a cell type of interest, and processing the resultant 
fragments for sequencing by ligating adapters to their ends, we can produce a sequencing 
library of DNA fragments that were DNase hypersensitive (111). Sequencing such fragments 
(DNase-sequencing) not only produces the least biased possible picture of the chromatin 
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landscape, but can also imply the binding of specific transcription factors within 
hypersensitive regions based on the slightly altered cleavage profile around their target 
sequences (112). 
However, the only way to assign the binding of an individual transcription factor to a distinct 
target site is by using an antibody of known specificity to pull down the factor along with the 
target site it is bound to. Known as chromatin immunoprecipitation (ChIP), this technique 
requires cells to be fixed and the DNA sheared into fragments of sequencable length before 
the antibody pull down. By ligating adapters to the ends of these fragments and performing 
massively parallel sequencing (ChIP-sequencing), we can capture a picture of the regions 
bound by an individual transcription factor genome wide within a population of cells (113). 
 
2.3   RNA  AND  PROTEIN  EXPRESSION  PROFILING  
The activities of individual cells are defined by the genes and proteins that they express. The 
ability to simultaneously capture the relative expression of every gene expressed in a cell has 
led to a much deeper understanding of the networks involved in regulating cell states and how 
specific actions are accomplished. Due to the ability to amplify nucleic acid sequences, RNA 
expression profiling has taken great strides as sequencing technology has improved. 
However, it is proteins that perform the actions of cells, and thus any information gleaned 
from RNA profiling must be confirmed on the protein level. 
RNA-sequencing technology has become so sensitive that it is estimated we can currently 
capture and sequence up to 40% of transcripts present in a single cell (114). Most of these 
techniques rely on the poly-adenylation of protein coding RNAs, which allows for them to all 
be simultaneously converted to DNA in a single reaction, though the analysis of non-coding, 
short RNAs has also recently reached single cell sensitivity (115). One of the most important 
innovations in reaching such sensitive levels of detection has been the engineering of the 
transposase enzyme. Since this enzyme has the intrinsic ability to cut DNA and 
simultaneously ligate an associated, foreign DNA fragment to it, this allows for the efficient 
generation of a library of sequencable fragments in a single step (116). Thus, the ability to 
capture all of the genes expressed in a population, or in single cells, has given us a global 
view of gene regulation and transcriptional networks. 
The ultimate output of RNA expression is on the protein level, where genes gain their ability 
to act within the cell. Although possible, it is much more difficult to gain a complete and 
unbiased picture of a cell’s proteome than its transcriptome (117). However, there are many 
layers of gene regulation between RNA and protein, and thus it is essential that any 
conclusions made from RNA expression data be confirmed on the protein level (118). The 
most common way to analyze protein expression pattern within a tissue is by using 
immunohistochemistry. The ability to conjugate fluorophores that are excited at different 
frequencies in the visible part of the electromagnetic spectrum to different antibodies 
simultaneously on the same sample has allowed us to look at the co-expression, and even co-
  17 
localization of proteins in vivo (119). This technique is complemented by western blotting, 
whereby proteins are separated based on size using gel electrophoresis and visualized 
individually by antibodies to see their relative levels in different samples. This method is 
indispensable for assessing the enrichment of a protein following functional assays (120). 
 
2.4   FUNCTIONAL  ASSESMENT  OF  PROTEIN  FUNCTION  
The activities of individual cells are defined by the genes and proteins that they express. The 
ability to simultaneously capture the relative expression of every gene expressed in a cell has 
led to a much deeper understanding of the networks involved in regulating cell states and how 
specific actions are accomplished. Due to the ability to amplify nucleic acid sequences, RNA 
expression profiling has taken great strides as sequencing technology has improved. 
However, it is proteins that perform the actions of cells, and thus any information gleaned 
from RNA profiling must be confirmed on the protein level. 
RNA-sequencing technology has become so sensitive that it is estimated we can currently 
capture and sequence up to 40% of transcripts present in a single cell (114). Most of these 
techniques rely on the poly-adenylation of protein coding RNAs, which allows for them to all 
be simultaneously converted to DNA in a single reaction, though the analysis of non-coding, 
short RNAs has also recently reached single cell sensitivity (115). One of the most important 
innovations in reaching such sensitive levels of detection has been the engineering of the 
transposase enzyme. Since this enzyme has the intrinsic ability to cut DNA and 
simultaneously ligate associated, foreign sequences to it, this allows for the efficient 
generation of a library of sequencable fragments in a single step (116). Thus, the ability to 
capture all of the genes expressed in a population, or in single cells, has given us a global 
view of gene regulation and transcriptional networks. 
The ultimate output of RNA expression is on the protein level, where genes gain their ability 
to act within the cell. Although possible, it is much more difficult to gain a complete and 
unbiased picture of a cell’s proteome than its transcriptome (117). However, there are many 
layers of gene regulation between RNA and protein, and thus it is essential that any 
conclusions made from RNA expression data be confirmed on the protein level (118). The 
most common way to analyze protein expression pattern within a tissue is by using 
immunohistochemistry. The ability to conjugate fluorophores that are excited at different 
frequencies in the visible part of the electromagnetic spectrum to different antibodies 
simultaneously on the same sample has allowed us to look at the co-expression, and even co-
localization of proteins in vivo (119). This technique is complemented by western blotting, 
whereby proteins are separated based on size using gel electrophoresis and visualized 
individually by antibodies to see their relative levels in different samples. This method is 
indispensable for assessing the enrichment of a protein following functional assays (120). 
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2.5   FUNCTIONAL  ASSESMENT  OF  CRM  ACTIVITY  
In order to understand how specific CRMs affect their target genes, there are several 
techniques utilized to infer where in the embryo they are active, the affinity of specific 
transcription factors for them and how those transcription factors affect their activities. 
Although general functions can be ascribed to different factors, it is only in the specific 
context of individual enhancers that conclusive statements about their roles in biological 
processes can be made. 
One of the first questions that genome wide transcription factor binding or chromatin 
accessibility data leads to is whether or not signals in these assays correspond to CRMs 
driving activation of their neighboring genes. Although electroporation can address where in 
the limited electroporated area a CRM is active (123), in order to assess activity throughout 
an embryo the manipulation must occur at an early developmental stage and be retained in 
every cell throughout development. Since fish eggs are large and develop externally, it is 
possible to inject special plasmids containing transposase recognition sites along with 
transpose mRNA directly into the single cell embryo. If the plasmid contains a CRM in 
proximity to a promoter and green fluorescent protein (GFP) reporter gene then, as the fish 
develops and the enhancer becomes active in specific cell types, distinct regions of the fish 
will fluoresce and reveal what tissues may utilize the enhancer (123). 
ChIP-sequencing is readily capable of revealing the CRMs to which a transcription factor is 
bound in vivo. However, the resolution of this technique is not capable of revealing the 
specific target motifs within a sequence that the transcription factor binds, nor the relative 
affinity that the transcription factor binds to different motifs. In order to reveal such deep 
mechanistic detail, DNA oligonucleotides can be radioactively labelled, mixed with purified 
transcription factor protein and incubated. When these mixes are run on a gel, the migration 
of oligonucleotides bound by protein will be retarded and form a band running with the 
protein. The relative intensity of such bands reveals the association between the protein of 
interest and each oligonucleotide sequence (125).  
However, even when binding to an individual motif has been established, an individual 
transcription factor’s effect on neighboring target gene activity is still an open question. 
Particularly in the presence of specific partner factors, transcription factors can activate or 
repress gene transcription to varying degrees. In order to pick apart these interactions and 
their functional effects on gene transcription, CRM regions are often cloned next to a 
promoter and the reporter gene luciferase. When these plasmids are transfected into cell lines 
or in vivo, the amount of luciferase protein produced can be assayed by an enzymatic reaction 
generating light. Thus, when expression plasmids coding for transcription factors that target 
the CRM are co-transfected, it is possible to assess their functional effects on basal CRM 
activity (126). 
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3   AIMS,  RESULTS  AND  DISCUSSION  
 
3.1   PAPERS  I  AND  II:  SPATIAL  PATTERNING  OF  GENE  EXPRESSION  IN  THE  
ENDODERM  AND  NEURAL  TUBE  
3.1.1   Aims  
Transcription factors are often broadly expressed in distal parts of the developing embryo, 
where they perform distinct and overlapping functions in each region where they are 
expressed. However, it has remained unclear to what extent the chromatin landscape and 
differential expression of partner factors specify gene expression through the activities of 
ubiquitously expressed transcription factors. In Papers I and II, we wished to understand how 
specific and overlapping gene expression patterns arise from differences in the activities of 
ubiquitous and specifically expressed transcription factors, and the chromatin landscapes of 
different cell types. 
3.1.2   Results  
In paper I, we performed ChIP-sequencing and RNA-sequencing on cortex, spinal cord, 
stomach and lung from E11.5 embryos. We find that the vast majority of SOX2 binding is 
cell type specific and associated with transcription factor binding motifs corresponding to 
factors specifically expressed in each organ. Moreover, while specific SOX2 binding reflects 
the distinct gene expression patterns of each region where it is detected, common SOX2 
bound CRMs are found around genes involved in core stem cell processes such as 
proliferation and the suppression differentiation. We go on to show that CRMs bound by 
SOX2 specifically in the endoderm or neural tube drive expression specifically in those 
organs, while CRMs bound in both germ layers are expressed in both. However, we do 
observe occurrences of ectopic reporter expression in the neural tube of CRMs bound 
exclusively in the endoderm, and find that these correspond to regions of inaccessible 
chromatin in the neural tube. Finally, we show that SOX2 represses proliferation in both the 
spinal cord and stomach, likely due to the binding of shared CRMs involved in proliferation. 
In paper II, we performed ChIP-sequencing, Prom1 sorted DNase-sequencing and Prom1 
sorted RNA-sequencing on the spinal cord and cortex. We find that DNAse hypersensitive 
sites (DHSs) are largely overlapping in these two regions, but that the relative accessibility of 
DHSs is predictive of differential expression in neighboring genes. We go on to show that 
SOX2 binding is mostly cell type specific, but that many specifically bound CRMs are within 
commonly accessible DHSs. Importantly, CRMs specifically bound by SOX2 in the spinal 
cord are enriched for HOXA9 binding motifs, while those in the cortex are enriched for 
LHX2 motifs, both of which can be found as footprints neighboring SOX-motifs in 
corresponding DHSs. Moving forward, we cloned CRMs commonly or specifically bound in 
cortex or spinal cord into GFP reporter vectors, and found them to drive expression only in 
the same region of the zebrafish embryo that SOX2 binding was detected. Moreover, CRM 
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reporter expression was found to require intact SOX2, LHX2 and HOXA9 motifs, and to 
even be repatterned to the inappropriate region of the neural tube when HOXA9 and LHX2 
motifs were swapped. The co-factor dependence of gene expression was further confirmed by 
sequencing cortical progenitors following electroporation of HOXB6, as spinal cord genes 
were upregulated under these conditions, and found to be associated with HOXA9 motif 
containing CRMs bound by SOX2 in spinal cord. Finally, this led us to a model whereby the 
presence of specifying transcription factor motifs guide distinct SOX2 binding profiles, 
which in turn leads to differential CRM accessibility – the single most predictive factor in 
divergent gene expression patterns. 
3.1.3   Discussion  
The question of how specific gene expression is achieved by transcription factor interactions 
within a defined chromatin landscape has important implications to both development and 
health, as deregulation of gene expression is an underlying cause of many diseases (126-127). 
In paper I, we find that the chromatin landscape plays an essential role in specifying CRM 
activity, as several endoderm specific CRMs showed ectopic activity in the neural tube when 
removed from their endogenous chromatin environment. This contrasts with our findings in 
paper II, whereby the chromatin landscape was found to be much more similar than the 
SOX2 binding profile in spinal cord and cortex. This suggests that the more closely related 
two tissues are, the more similar their chromatin landscapes (27) and thus the more essential 
the proper patterning of specific transcription factors becomes to proper genes expression. 
This conclusion is supported by the finding that switching the specific transcription factor 
motifs in CRM reporters is capable of respecifying their activities, and that the misexpression 
of HOXB6 in the cortex upregulated spinal cord genes neighboring HOXA9 motif containing 
CRMs bound by SOX2 in the spinal cord. Thus, we arrive at a model whereby specific 
transcription factors guide ubiquitous ones to distinct CRMs, where these complexes increase 
CRM accessibility and the expression of neighboring genes. However, following lineage 
commitment, as between the endoderm and neural tube, CRM accessibility becomes 
sufficiently restricted as to override the activities of transcription factors. 
Although we found that SOX2 binding is highly divergent in the different organs that we 
study in paper I, it has been repeatedly shown that SOX2 has shared stem cell activities in 
many of the systems it has been studied (128-130). The ability of SOX2 to suppress 
differentiation and maintain a stem cell state regardless of context suggests that it might do 
this via the same target genes bound in many cell types. In line with the role of SOX2 as a 
master regulator of the stem cell state (40, 96), we find that, despite binding only 232 genes in 
both the endoderm and neural tube, these genes include key regulators of the Wnt, Shh, 
Hippo and Notch pathways. Moreover, we find that many of these genes are directly involved 
in cell cycle regulation and that, by manipulating its levels using electroporation, SOX2 
represses cell proliferation in the spinal cord and stomach. Thus, SOX2 maintains its shared 
functions in different stem cell populations by binding common genes involved in key stem 
cell processes. 
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3.2   PAPERS  III  AND  IV:  REGULATION  OF  STEM  CELL  PROLIFERATION  IS  
ESSENTIAL  TO  TEMPORAL  CELL  FATE  COMMITMENT  
3.2.1   Aims  
The mammalian cortex is a powerful system for studying cell fate commitment due to the 
impeccably timed sequential differentiation of neuronal subtypes and glia from a stem cell 
population that is maintained throughout life. However, since the cortical ventricular zone is a 
mixed population of differentiating cells, the mechanism of stem cell competence progression 
has remained controversial (131-134). As a core stem cell process, cell cycle regulation has a 
key role in stem cell maintenance and competence progression, though the mechanics that 
underpin this relationship have remained elusive. In papers III and IV, we wished to 
understand the mechanisms connecting stem cell maintenance to cell cycle regulation and 
temporal cell fate commitment. 
3.2.2   Results  
In paper III, we utilized single cell RNA-sequencing to analyze cells from E9.5, E11.5, 
E13.5, E15.5 and E18.5 in order to study stem cell competence progression from deep to 
upper layer neuronal fate production. Using a t-distributed neighbor embedding (tSNE) based 
adjacency matrix to cluster our cells, we charted neurogenesis through our single cells along 
two streams, corresponding to deep and upper layer neuronal fates. This structure allowed us 
to perform differential expression analysis between cell clusters of similar neurogenic 
maturation stage in order to find lineage specific genes, and to group these genes based on 
their shared expression patterns within our data set. This analysis revealed not only a 
multipotent group of E11.5 stem cells that clustered together with upper layer stem cells, but 
also that the defining characteristic of this relationship was their shared expression of genes 
involved in mitosis. In contrast, other E11.5 cells that fell further along the stream towards 
deep layer neuron commitment expressed higher levels of markers for the G1 and S-phases of 
the cell cycle. 
In order to characterize the cell fate competence of these different groups of progenitors, we 
identified cell surface markers of each in our RNA-sequence data, fluorescence activated cell 
sorted (FACS) E11.5 progenitors based on their expression of these markers and 
differentiated them in vitro. Indeed, the cells that expressed markers of the multipotent group 
(Hmmr, Gpc6, Ednrb or high Sox2 levels) were much more likely to be found in M-phase and 
to differentiate into upper layer neurons when compared to those expressing markers of the 
committed clusters (Slc1a5, Efna5 or low Sox2 levels). This raised the question of whether 
cell cycle phase might be instructive to temporal cell fate decisions. To address this 
possibility, we overexpressed and knocked down CCNB1/2 and CCND1/2, which license M- 
and G1-S phase progression, respectively. We found that the overexpression of CCNB1/2 or 
knockdown of CCND1 made progenitors assume an upper layer neuronal fate, while the 
overexpression of CCND1 or knock down of CCNB1/2 was capable of biasing neurogenesis 
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towards deep layer fates. Finally, bulk RNA-sequencing of our sorted populations and 
electroporated cells revealed the TGFß and Notch signaling pathways to be commonly 
upregulated in early progenitors that go on to produce upper layer neurons. 
In paper IV, we used a subset of our cortex single cell RNA-sequence data set and 
immunohistochemistry to show that markers of active proliferation, including BrdU 
incorporation and phosphohistone 3 (PH3) staining, are negatively correlated with 
Sox2/SOX2 expression levels. Moreover, by manipulating SOX2 levels using in utero 
electroporation, we observed that its overexpression reduced proliferation, while knock down 
increased proliferation. Importantly, we also saw that Sox2/SOX2 levels negatively correlated 
with markers of differentiation, and that forcing differentiation by knocking down SOX2 or 
overexpressing NEUROG2 induced a transient increase in proliferation. In order to 
understand the mechanisms by which SOX2 suppressed proliferation and differentiation, we 
compared cortex SOX2 ChIP-sequencing profiles to genes differentially regulated following 
the overexpression or knockdown of SOX2. Genes negatively regulated by SOX2were found 
to be enriched for cell cycle genes, and though several of these were able to increase BrdU 
incorporation upon overexpression, only CCND1 completely retained this capacity when co-
electroporated with SOX2. As a potential downstream target, we found that the Ccnd1 
promoter was one of the most robustly occupied regions in the genome, contained several 
SOX motifs of varying affinity for SOX2 binding, and was repressed in a dose dependent 
fashion by SOX2 in reporter assays. Interestingly, we found this repressive capacity to be 
dependent on the off consensus SOX motifs in the promoter region, which were most weakly 
bound in EMSA assays, and that these were characteristic of CRMs around genes repressed 
by SOX2 genome wide.  
Importantly, the Ccnd1 promoter is a known target of the Wnt pathway and, while 
overexpression of stabilized ß-catenin activated the promoter and cell proliferation, co-
overexpression of SOX2 completely blocked this capacity. We found that it was this SOX2 
function that required the on consensus sites in the Ccnd1 promoter and that this relied on an 
interaction with, Wnt signal transducing, TCF/LEF transcription factors. Moreover, we saw 
that TCF/LEF motifs were associated with genes repressed by SOX2 genome wide when 
spaced between five and nine bases from a consensus SOX motif. Notably, we could show 
that SOX2 bound to the TCF/LEF co-repressor TLE1, and that the presence of SOX2 
increased the association between LEF1 and TLE1 in a dose dependent fashion. Conversely, 
we found that not only did TLE1 repress the Ccnd1 promoter and proliferation, but that this 
capacity required SOX2, and that a LEF1 protein lacking the ability to bind TLE1 could 
block SOX2’s effects on proliferation and Ccnd1 promoter activity. 
3.2.3   Discussion  
Temporal cell fate competence progression can only occur within uncommitted stem cell 
populations, many of which will eventually reside in adult tissues throughout life. Thus, the 
first major issue facing the analysis of this process is to identify the stem cells within the 
complex population of progenitors at varying levels of commitment. By using single cell 
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RNA-sequencing in paper III, we have taken one of the first genome wide pictures of this 
complexity and used it to identify mechanisms involved in stem cell fate progression. We 
find that stem cell maintenance and temporal competence progression are profoundly tied 
together in the core processes involved in cell cycle progression, and in paper IV we work out 
a direct mechanistic link between these. 
There has been a debate in the field as to whether CUX2+ cells in the early cortical 
ventricular zone are fate restricted to generate neurons of the upper cortical layers (131-134). 
This would suggest that cortical stem cells do not temporally progress in their cell fate 
competence over time, but instead become committed to a specific fate very early in 
development and are then activated in a defined temporal order (131, 133). However, our 
data in paper III does not support this model, as even though we do find a population of early 
stem cells that shows a close molecular link to upper layer progenitors, these cells are still 
highly related to the other early progenitor populations, and express markers of deep layer 
lineages. Moreover, although these cells do show an increased competence for upper layer 
neurogenesis when we FACS sort them from the overall population and differentiate them, 
we find that they also produce many deep layer neurons as well. Thus, we prefer a model 
whereby this population is best characterized as the least differentiated stem cells in the 
ventricular zone, which retain a multipotent capacity for differentiation into multiple cortical 
lineages. This contrasts with other cell populations in the early cortical ventricular zone, 
which are unipotent and found at various stages of commitment to deep layer neurogenesis. 
It was surprising to us to find that cell cycle phase specific genes were so prominent in 
segregating multipotent stem cells from unipotent progenitors in our single cell RNA-seq data 
in paper III. However, it is interesting to note that a link between CCNB1 and pluripotency 
maintenance in ESCs was also recently made using an unbiased screening approach (68), 
while in the same system, CCND1-3 activity has been shown to be involved in germ layer 
specification and differentiation by directly activating the genes responsible (69). Moreover, 
other cell cycle regulators, such as Rb and Cdc25, have also been implicated in stem cell 
maintenance and cell fate decisions (135, 136). These precedents suggest that similar 
mechanisms may be utilized during cortical development, though how they are then applied 
to this specific systems is an open question. Interestingly, when we sequenced cortical cells 
electroporated with CCNB1, we found that both Notch and TGFß pathway components were 
upregulated. This fits with roles in the simultaneous inhibition of differentiation and 
progression of cell fate competence, as TGFß was also identified to maintain pluripotency in 
the aforementioned study (68) and has been shown to perform this function in another neural 
stem cell system (137). Furthermore, these roles contrast with those of CCND1, which has 
been previously shown to induce commitment to differentiation in both the cortex and spinal 
cord (75, 138). Our data supports this conclusion, and suggests it may perform this function 
via Myc and chemokine pathways, both of which have been shown to induce differentiation 
in different neurogenic systems (139-140). Although these indirect mechanisms surely play a 
role in cyclin dependent regulation of cell fate commitment, the finding that CCND1 binds 
directly to specific target genes in ESCs suggests that there may also be mechanisms that 
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allow these factors to directly inhibit or execute context specific differentiation programs 
(69). 
The ability of different cyclins to so powerfully influence stem cell maintenance suggests that 
regulating the expression of these factors must be incorporated into the transcriptional 
networks essential to these processes. SOX2 is amongst the best characterized stem cell 
factors, as its levels have been shown to be inversely correlated with differentiation in the 
ventral forebrain (98), it is a core component of the ESC pluripotency network (40) and its 
overexpression was key to the discovery of somatic cell reprogramming (99). Thus, it is 
surprising that the mechanisms by which SOX2 actually maintains stemness in different 
contexts remain largely uncharacterized. In paper IV, we find that, at high levels, SOX2 
maintains stem cells in a slowly cycling state, while differentiation involves a transient burst 
of proliferation. The mechanistic insight that SOX2 binds off-consensus motifs to perform 
this function has precedent in the drosophila embryo, and likely has widespread implications 
in many cellular processes (141). Interestingly, quiescence is a well characterized property of 
adult and cancer stem cell populations, but a slow cell cycle has only recently been ascribed 
to stem cells in the embryo (142-143). As cancer stem cells have also been shown to 
upregulate pluripotency factors (144), the direct mechanistic link that we have found between 
these traits represents a potential pathway for identifying and targeting them within tumors. 
These findings also highlight the intrinsic contradiction in tackling cancer, as the cells that are 
most dangerous and difficult to kill are often a small population of slowly cycling cells that 
are largely unaffected by traditional treatments (145). 
When considering the role of stem cells in cancer, it is important to look for commonalities 
within this diverse disease. Two of the main drivers of many cancers are mutations that 
hyperactivate the Wnt pathway (146) or inactivate the TP53 pathway (85). As discussed 
above, the signaling networks downstream of these pathways are intrinsically linked with cell 
cycle regulation and stem cell maintenance. Although many SOX proteins have been shown 
to influence the Wnt pathway, most of these studies have lacked mechanistic insight into how 
SOX proteins achieve their effects in a context specific manner (147). By demonstrating the 
HMG-domain dependent binding of SOX2 and TCF/LEF transcription factors, as well as the 
functional effect that SOX2 has on the transcriptional output of this complex, we uncover a 
DNA-motif that is likely to play important roles in diverse contexts, such as sex 
determination (146), cancer (128) and organ maintenance in diverse tissues (147, 149). 
Moreover, although we do not address TP53 directly in this work, it is interesting to note that 
the upstream ATM/ATR and CHEK1/2 kinases were also identified as maintaining 
pluripotency in the aforementioned screen (68). This network is linked to SOX2 via SOX5, 
SOX6 and SOX21, which are upregulated upon SOX2 overexpression, and have recently 
been shown to play an essential role in the activation of the P53 pathway under oncogenic 
stress (101). Although only a small component of a stem cell transcriptional network, SOX 
protein cross regulation is yet another example of their key role in balancing stemness and 
differentiation in multiple contexts. Thus, the Sox family of transcription factors is integrally 
linked with the core pathways of stem cell maintenance via multiple mechanisms, and fully 
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understanding their activities will be key to gaining insight into stem cell linked diseases such 
as cancer.
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